Stay updated on Cusatuzumab Combo for AML Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo for AML Clinical Trial page.

Latest updates to the Cusatuzumab Combo for AML Clinical Trial page
- Check2 days agoChange DetectedA Record History section and a version history table were added to show chronological updates to the study record, including statuses and changes across versions.SummaryDifference32%

- Check9 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating a platform version bump.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record history now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects the posting of a newer version of the record.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history shows a new Revision: v3.6.3 replacing v3.6.2, indicating a small platform update. No study data or content are altered.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's Revision indicator was updated from v3.6.0 to v3.6.2, reflecting a newer build of the history interface.SummaryDifference0.1%

- Check67 days agoChange DetectedIn the latest history entry, the study is shown as no longer looking for participants, indicating that recruitment has ceased. The version also adds the revision label v3.6.0 and removes the previous label v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Cusatuzumab Combo for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo for AML Clinical Trial page.